Cannula Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Cardiac, Dermatology, Nasal, Others), By Type (Neonatal Cannulae, Straight Cannulae, Winged Cannulae, Wing With Port, Winged With Stop Cork), By Material (Plastic, Metal, Silicone), By Size (14G, 16G, 18G, 20G, 22G, 24G, 26G), By End-Use Industry (Hospital, Ambulatory Surgical Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 226.59 Million
CAGR (2026-2031)	7.91%
Fastest Growing Segment	Cardiac
Largest Market	North America
Market Size (2031)	USD 357.78 Million

Market Overview

The Global Cannula Market will grow from USD 226.59 Million in 2025 to USD 357.78 Million by 2031 at a 7.91% CAGR. A cannula is defined as a flexible tube, typically incorporating a retractable inner core, inserted into a bodily cavity, duct, or vessel to drain fluid or administer medication. The market is fundamentally driven by the rising prevalence of chronic conditions requiring long-term intravenous therapy and the expanding geriatric population, which naturally increases hospitalization rates. Furthermore, the global shift toward minimally invasive medical procedures necessitates the consistent utilization of these devices for precise vascular access and fluid management, ensuring sustained demand distinct from temporary trends.

However, the risk of catheter-related bloodstream infections remains a significant impediment to market expansion, resulting in stricter regulatory oversight and elevated healthcare costs. This critical need for safer vascular access is substantiated by high disease burden statistics; according to the American Heart Association, in 2025, cardiovascular disease accounted for approximately 19.41 million global deaths in the most recent comprehensive data, underscoring the immense scale of patients requiring medical intervention.

Key Market Drivers

The growing demand for aesthetic and cosmetic medical treatments has emerged as a pivotal driver for the global cannula market, specifically fueling the adoption of blunt-tip microcannulas. These specialized devices are increasingly preferred over traditional hypodermic needles for soft tissue filler injections due to their ability to minimize patient bruising, reduce pain, and significantly lower the risk of vascular occlusion. This industry shift is substantiated by the rapid expansion of the non-invasive sector; according to the International Society of Aesthetic Plastic Surgery, June 2025, in the 'Global Survey 2024 Press Release', non-surgical procedures surged to reach approximately 20.5 million operations worldwide. This trend forces manufacturers to innovate with flexible, safety-engineered designs tailored for precise facial contouring, thereby creating a high-value niche within the broader vascular access industry.

Simultaneously, the rising global prevalence of chronic lifestyle and respiratory diseases necessitates consistent, long-term therapeutic interventions, anchoring the market's core volume. Conditions such as diabetes and chronic obstructive pulmonary disease (COPD) require frequent medication delivery or continuous oxygen therapy, sustaining the need for high-quality intravenous and nasal cannulas. For instance, according to the International Diabetes Federation, in 2025, in the 'IDF Diabetes Atlas 11th Edition', an estimated 589 million adults were living with diabetes globally, a patient base heavily reliant on insulin delivery systems. This widespread disease burden ensures steady revenue streams for medical device companies; according to ICU Medical, November 2025, in the 'Third Quarter 2025 Financial Results', the firm reported quarterly revenues of approximately $537 million, reflecting the enduring demand for essential infusion and critical care consumables.

Download Free Sample Report

Key Market Challenges

The persistent risk of catheter-related bloodstream infections and associated vascular access complications stands as a formidable barrier to the growth of the Global Cannula Market. This safety challenge significantly hampers market expansion by triggering stringent regulatory oversight and escalating liability concerns for healthcare institutions. As regulatory bodies enforce tighter safety standards to mitigate these risks, manufacturers are compelled to invest heavily in compliance and quality assurance, which increases production costs and extends the approval timelines for new devices. These economic and procedural obstacles create high barriers to entry and slow the introduction of innovative products, thereby restricting the overall pace of market development.

The severity of this issue is underscored by the high frequency of device-related issues in clinical settings. According to the Association for Vascular Access, in 2024, the prevalence of peripheral intravenous catheter failure ranged from 35% to 50% in hospitalized patients. This substantial failure rate forces medical facilities to allocate significant financial resources toward treating complications and performing re-insertion procedures. Consequently, hospitals often adopt conservative procurement strategies, prioritizing rigorous validation over volume, which directly constrains the rapid adoption and volume growth of cannula products globally.

Key Market Trends

Healthcare facilities are increasingly standardizing the use of safety IV cannulas equipped with automatic needle-shielding mechanisms to mitigate occupational hazards. This trend is a direct response to stricter safety regulations aimed at eliminating needle-stick injuries among healthcare workers and preventing cross-contamination during vascular access procedures. Manufacturers are aggressively expanding production capabilities to meet this regulatory-driven demand for protective devices. According to Becton, Dickinson and Company, January 2025, in the 'BD Boosts U.S. Manufacturing of Critical Medical Devices' press release, the company announced investments to boost its manufacturing capacity for safety-engineered injection devices by more than 40 percent to support critical healthcare delivery needs.

Simultaneously, there is a distinct shift toward designing user-friendly cannulas for home-based healthcare settings, particularly for respiratory therapy and long-term infusion. As care delivery moves from hospitals to patient homes, demand is surging for durable, low-maintenance devices that allow patients to manage chronic conditions like sleep apnea and respiratory distress independently. This migration to home care is generating substantial revenue growth for specialized device manufacturers. According to Fisher & Paykel Healthcare, May 2025, in the 'Annual Report 2025', revenue for the Homecare product group, which comprises devices for community-based respiratory support, reached approximately $740 million, reflecting a 13% increase compared to the previous financial year.

Segmental Insights

The cardiac segment is currently positioned as the fastest-growing category within the global cannula market. This expansion is primarily driven by the rising global prevalence of cardiovascular diseases, which necessitates a higher volume of surgical interventions. Reports regarding disease burden from the World Health Organization indicate that increasing heart conditions directly correlate with surging demand for medical support devices. Consequently, healthcare facilities are utilizing more cardiac cannulas for critical procedures such as cardiopulmonary bypass, thereby sustaining the rapid development of this specific market segment.

Regional Insights

North America maintains a dominant position in the global cannula market due to established healthcare infrastructure and a high volume of surgical procedures. This leadership is reinforced by the increasing prevalence of chronic diseases requiring intravenous therapy and minimally invasive surgeries. Additionally, the region benefits from favorable reimbursement policies established by the Centers for Medicare & Medicaid Services, which support patient access to essential medical devices. The strong presence of key industry manufacturers and rigorous product approvals by the U.S. Food and Drug Administration further solidify market stability and expansion within this region.

Recent Developments

• In January 2025, Becton, Dickinson and Company announced a strategic investment of $30 million to expand its manufacturing capacity for intravenous catheters at its facility in Sandy, Utah. This capital allocation was part of a broader initiative to strengthen the domestic supply chain for critical medical devices and ensure the availability of essential vascular access products. The project aimed to significantly increase the annual production output of the company's safety-engineered IV cannulas to meet rising demand from healthcare providers. This development highlighted the company's ongoing efforts to support healthcare infrastructure and maintain market leadership in vascular access solutions.
• In December 2024, Teleflex Incorporated launched the Pressure Injectable Arrowg+ard Blue Plus MSB Procedure Kit in the Europe, Middle East, and Africa regions. This product introduction expanded the company’s central vascular access portfolio by offering a central venous catheter equipped with advanced antimicrobial protection to mitigate the risk of catheter-related bloodstream infections. The device was also designed with pressure-injectable capabilities, providing clinicians with enhanced versatility for fluid management and diagnostic imaging. This launch demonstrated the company's focus on combining infection control efficacy with operational efficiency in critical care environments.
• In November 2024, ClearPoint Neuro, Inc. received marketing approval from the U.S. Food and Drug Administration for its SmartFlow Neuro Cannula. This regulatory milestone enabled the company to commercialize the device for use in minimally invasive neurosurgical procedures, specifically for the targeted delivery of therapeutic agents to the brain. The cannula was engineered to ensure precise placement and minimize reflux during drug administration, facilitating direct-to-CNS therapies. This development represented a significant expansion of the company's neuro-navigation product suite, addressing specialized needs for precision tools in the neurological sector of the global cannula market.
• In September 2024, B. Braun SE announced that it had received 510(k) clearance from the U.S. Food and Drug Administration for the Introcan Safety 2 Deep Access IV Catheter. This new device was added to the company's vascular access portfolio to assist clinicians in establishing peripheral intravenous access in patients with difficult venous conditions. The product featured a longer catheter length designed to reach deeper veins while incorporating passive safety mechanisms to protect healthcare workers from needlestick injuries. This launch underscored the company's commitment to advancing safety standards and improving procedural success rates within the peripheral cannula market segment.

Key Market Players

• Medtronic plc
• Becton Dickinson (BD) & Company
• Edward Lifesciences Corporation
• LivaNovaca plc
• Smiths Medical MD Inc
• Boston Scientific Corporation
• Hindustan Syringes and Medical Devices Ltd
• Sterimedix Ltd.
• Angiplast Pvt. Ltd
• Sterimed Group

By Product	By Type	By Material	By Size	By End-Use Industry	By Region
Cardiac Dermatology Nasal Others	Neonatal Cannulae Straight Cannulae Winged Cannulae Wing With Port Winged With Stop Cork	Plastic Metal Silicone	14G 16G 18G 20G 22G 24G 26G	Hospital Ambulatory Surgical Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Cannula Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Cannula Market, By Product:

• Cardiac
• Dermatology
• Nasal
• Others

• Cannula Market, By Type:

• Neonatal Cannulae
• Straight Cannulae
• Winged Cannulae
• Wing With Port
• Winged With Stop Cork

• Cannula Market, By Material:

• Plastic
• Metal
• Silicone

• Cannula Market, By Size:

• 14G
• 16G
• 18G
• 20G
• 22G
• 24G
• 26G

• Cannula Market, By End-Use Industry:

• Hospital
• Ambulatory Surgical Centers
• Others

• Cannula Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE